International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Items 901–1,000 of 1,132
Usami, T., Yokoyama, M., Ueno, M., Iwama, N., Sagawa, N., Kawano, R., Waguri, M., Sameshima, H., Hiramatsu, Y., Sugiyama, T., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13101 · Cited by 44
Early Gestational Diabetes Mellitus: Diagnostic Strategies and Clinical Implications
Bhattacharya, S., Nagendra, L., Krishnamurthy, A., Lakhani, O. J., Kapoor, N., Kalra, B., & Kalra, S. (2021) · Medical Sciences · doi:10.3390/medsci9040059 · Cited by 43
Gestational Diabetes Mellitus: Screening and Outcomes in Southern Italian Pregnant Women
Capula, C., Chiefari, E., Vero, A., Arcidiacono, B., Iiritano, S., Puccio, L., Pullano, V., Foti, D. P., Brunetti, A., & Vero, R. (2013) · ISRN Endocrinology · doi:10.1155/2013/387495 · Cited by 43
Wang, W.-J., Huang, R., Zheng, T., Du, Q., Yang, M., Xu, Y., Liu, X., Tao, M., He, H., Fang, F., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.875180 · Cited by 44
Chehab, R. F., Ferrara, A. M., Greenberg, M., Ngo, A. L., Feng, J., & Zhu, Y. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.33955 · Cited by 45
Benton, M., Silverio, S. A., & Ismail, K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288395 · Cited by 45
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 85
Diagnosis of Gestational Diabetes Mellitus in China
Zhu, W.-W., & Yang, H.-X. (2013) · Diabetes Care · doi:10.2337/dc12-2624 · Cited by 40
Kong, J. M., Lim, K. I., & Thompson, D. M. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.09.007 · Cited by 46
Coutinho, W. F., & Júnior, W. S. D. S. (2015) · Annals of Global Health · doi:10.1016/j.aogh.2015.12.010 · Cited by 56
Fasting glycaemia to simplify screening for gestational diabetes
Rüetschi, J. R., Jornayvaz, F. R., Rivest, R., Huhn, E., Irion, O. P., & Boulvain, M. (2016) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13857 · Cited by 50
Ravnsborg, T., Andersen, L. L. T., Trabjerg, N. D., Rasmussen, L. M., Jensen, D. M., & Overgaard, M. (2016) · Diabetologia · doi:10.1007/s00125-016-3869-8 · Cited by 52
Lin, P., Lin, W., Yeh, Y.-H., & Wung, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153044 · Cited by 46
Caissutti, C., & Berghella, V. (2017) · BioMed Research International · doi:10.1155/2017/2746471 · Cited by 36
Carreiro, M. P., Nogueira, A. I., & Ribeiro‐Oliveira, A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020011 · Cited by 43
“It is noteworthy, however, that the ADA [1] considers both the one-step criteria proposed by IADPSG [6], and the two-step method supported by ACOG [10] as acceptable.”
BackgroundMethodInfluentialAl-ofi, E. A., Mosli, H. H., Ghamri, K. A., & Ghazali, S. M. (2018) · Journal of International Medical Research · doi:10.1177/0300060518809872 · Cited by 50
Sarina, S., Li, D. F., Feng, Z. Q., Du, J., Zhao, W. H., Huang, N., Jia, J. C., Wu, Z. Y., Alamusi, Wang, Y. Y., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00713-z · Cited by 44
Wani, K., Sabico, S., Alnaami, A. M., Al-Musharaf, S., Fouda, M. A., Turkestani, I. Z., Al-Ajlan, A., Alshingetti, N. M., Alokail, M. S., & Al-Daghri, N. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00098 · Cited by 39
Caracho, R. A., Foratori-Júnior, G. A., Fusco, N. D. S., Jesuino, B. G., Missio, A. L. T., & Peres, S. H. D. C. S. (2020) · International Dental Journal · doi:10.1111/idj.12547 · Cited by 49
Gao, S., Leng, J., Liu, H., Wang, S., Li, W., Wang, Y., Hu, G., Chan, J. C. N., Yu, Z., Zhu, H., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000909 · Cited by 45
Early triglyceride and glucose index as a risk marker for gestational diabetes mellitus
Sánchez‐García, A., Rodríguez‐Gutiérrez, R., Saldívar‐Rodríguez, D., Guzmán‐López, A., Mancillas‐Adame, L. G., González‐Nava, V., Santos-Santillana, K. M., & González‐González, J. G. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13311 · Cited by 43
Hou, Y., Li, S., Xia, L., Yang, Q., Zhang, L., Zhang, X., Liu, H., Huo, R., Cao, G., Huang, C., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.142085 · Cited by 45
Association between maternal triglycerides and disturbed glucose metabolism in pregnancy
Eppel, D., Feichtinger, M., Linder, T., Kotzaeridi, G., Rosicky, I., Yerlikaya‐Schatten, G., Eppel, W., Husslein, P. W., Tura, A., & Göbl, C. S. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01644-z · Cited by 50
Teshome, A. A., Li, Q., Garoma, W., Chen, X., Wu, M., Zhang, Y., Zhang, X., Lin, L., Wang, H., Yang, X., et al. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.01.016 · Cited by 53
Simmons, D. (2021) · Diabetes Care · doi:10.2337/dci20-0055 · Cited by 38
Increasing trend in the prevalence of gestational diabetes mellitus in Taiwan
Su, F.-L., Lu, M., Yu, S., Yang, C., Yang, C., Tseng, S., & Yan, Y. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13595 · Cited by 48
Wang, Y., Sun, F., Wu, P., Huang, Y., Ye, Y., Yang, X., Yuan, J., Liu, Y., Zeng, H., Wen, Y., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab637 · Cited by 43
Prediction of insulin treatment in women with gestational diabetes mellitus
Eleftheriades, M. I., Chatzakis, C., Papachatzopoulou, E., Papadopoulos, V. G., Lambrinoudaki, I. V., Dinas, K. D., Chrousos, G. P., & Sotiriadis, A. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00173-0 · Cited by 51
Black, M. H., Zhou, H., Sacks, D. A., Dublin, S., Lawrence, J. M., Harrison, T. N., & Reynolds, K. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000646 · Cited by 50
“OGTT results were used to identify women with GDM based on recent International Association of Diabetes in Pregnancy Study Group (IADPSG) guidelines (at least one OGTT value: fasting 92mg/dl, 1-h 180 mg/dl, 2-h 153 mg/dl) [30].”
MethodOrtega, M. A., Fraile‐Μartinez, O., Montero, C. G., Paradela, A., Sánchez-Gil, M. A., Rodriguez-Martín, S., León-Luis, J. A. D., Pereda-Cerquella, C., Buján, J., Guijarro, L. G., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1060850 · Cited by 53
“Groups (IADPSG) (Metzger et al., 2010), detection and diagnosis of GDM is usually performed by an oral glucose tolerance test (OGTT), considering the following criteria: 1) FIGURE 2 The role of PEVs in PE.”
MethodPrevalence of gestational diabetes mellitus in Pakistan: a systematic review and meta-analysis
Adnan, M., & Aasim, M. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06290-9 · Cited by 42
Satı, L., Soygur, B., & Çelik-Özenci, Ç. (2015) · Reproductive Sciences · doi:10.1177/1933719115602765 · Cited by 44
“However, the overall staining intensity was observed to be weak in normal term compared to placenta samples from GDM.”
BackgroundInfluentialImam, K. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_4 · Cited by 44
Middleton, P., & Crowther, C. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009578.pub2 · Cited by 50
Yamashita, H., Yasuhi, I., Fukuda, M., Kugishima, Y., Yamauchi, Y., Kuzume, A., Hashimoto, T., Sugimi, S., Umezaki, Y., Suga, S., et al. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0163 · Cited by 45
Josefson, J. L., Reisetter, A. C., Scholtens, D. M., Price, H. E., Metzger, B. E., & Langman, C. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150221 · Cited by 44
Trends in the Diagnosis of Gestational Diabetes Mellitus
Mishra, S., Rao, C. R., & Shetty, A. (2016) · Scientifica · doi:10.1155/2016/5489015 · Cited by 42
“Outcome (HAPO) study from where Fasting: 92mg/dL International Association of the Diabetes and Pregnancy Study Group (IADPSG) criteria [23]”
BackgroundNing, H., Tao, H., Weng, Z., & Ζhao, X. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0867-8 · Cited by 46
Bgeginski, R., Ribeiro, P. A. B., Mottola, M. F., & Ramos, J. G. L. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12519 · Cited by 44
“The diagnosis of GDM is made using a singlestep 75-g oral glucose tolerance test when one or more of the following results are recorded during routine testing between 24 and 28 weeks of pregnancy: (i) fasting plasma glucose ≥92 mg/dL; (ii) 1-h post-load glucose ≥180 mg/dL; and (iii) 2-h post-load glucose ≥153 mg/ dL.(…”
BackgroundMethodInfluentialHildén, K., Hanson, U., Persson, M., Magnuson, A., Simmons, D., & Fadl, H. (2019) · Diabetic Medicine · doi:10.1111/dme.13843 · Cited by 42
Association between phthalate exposure and blood pressure during pregnancy
Han, X., Li, J., Wang, Y., Xu, S., Li, Y., Liu, H., Zhou, Y. R., Zhao, H., Fang, J., Cai, Z., et al. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.109944 · Cited by 44
Mussa, J., Meltzer, S., Bond, R., Garfield, N., & Dasgupta, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041454 · Cited by 46
Zhan, Y., Wang, J., He, X., Huang, M., Yang, X., He, L., Qiu, Y., & Lou, Y. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.02.023 · Cited by 45
Majewska, A., Stanirowski, P. J., Wielgoś, M., & Bomba-Opon, D. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102932 · Cited by 43
Gui, J., Rohrbach, A., Borns, K., Hillemanns, P., Feng, L., Hubel, C. A., & von Versen‐Höynck, F. (2015) · Placenta · doi:10.1016/j.placenta.2015.01.195 · Cited by 42
“The diagnostic standard for GDMwas based on International Association of Diabetes and Pregnancy Study Groups criteria [26].”
MethodLekva, T., Bollerslev, J., Godang, K., Roland, M. C. P., Friis, C. M., Voldner, N., Henriksen, T., & Ueland, T. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0153 · Cited by 42
Cai, Q., Liu, H., Han, W., Liu, L., Xu, Y., He, Y., Li, Q., Zhang, M., Hu, A., & Zheng, Y. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13105 · Cited by 42
Sharp, G. C., Schellhas, L., Richardson, S. S., & Lawlor, D. A. (2019) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174419000072 · Cited by 47
Metabolomics of Diabetes in Pregnancy.
McCabe, C. F., & Perng, W. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0890-3 · Cited by 41
Different intensities of glycaemic control for women with gestational diabetes mellitus
Martis, R., Brown, J., Alsweiler, J., Crawford, T. J., & Crowther, C. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011624.pub2 · Cited by 41
Li, H., Liu, S., Chen, H., Zhou, L., Chen, B., Wang, M., Zhang, D., Han, T.-L., & Zhang, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122744 · Cited by 46
Zhang, Q., Yuan, X., Luan, X., Lei, T., Li, Y., Chu, W., Yao, Q., Baker, P. N., Qi, H., & Li, H. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01028-x · Cited by 49
The diagnostic criteria for gestational diabetes: to change or not to change?
Reece, E. A., & Moore, T. R. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.887 · Cited by 48
Endogenous galanin as a novel biomarker to predict gestational diabetes mellitus
Zhang, Z., Gu, C., Fang, P., Shi, M., Wang, Y., Peng, Y., Ping, B., & Zhu, Y. N. (2014) · Peptides · doi:10.1016/j.peptides.2014.01.024 · Cited by 43
Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study
Erol, O. Ö., Erkal, N., Ellidağ, H. Y., İsenlik, B. S., Aydın, Ö., Derbent, A. U., & Yılmaz, N. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2016.1142967 · Cited by 43
Koning, S. H., Hoogenberg, K., Scheuneman, K. A., Baas, M. G., Korteweg, F. J., Sollie, K. M., Schering, B. J., van Loon, A. J., Wolffenbuttel, B. H. R., van den Berg, P. P., et al. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0136-4 · Cited by 41
Blažević, S. A., Horvatiček, M., Kesić, M., Zill, P., Hranilović, D., Ivanišević, M., Desoyé, G., & Štefulj, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179934 · Cited by 42
Maternal and perinatal outcome in gestational diabetes mellitus in a Tertiary Care Hospital in Delhi
Dalal, V., Kumari, R., Kachhawa, G., Sahoo, I., Khadgawat, R., Mahey, R., Kulshrestha, V., Vanamail, P., Sharma, J., Bhatla, N., et al. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_582_17 · Cited by 49
Lessons learned from lifestyle prevention trials in gestational diabetes mellitus
Egan, A. M., & Simmons, D. (2019) · Diabetic Medicine · doi:10.1111/dme.13772 · Cited by 39
Cosson, E., Vicaut, É., Sandre-Banon, D., Gary, F., Pharisien, I., Portal, J.-J., Banu, I., Bianchi, L., Cussac-Pillegand, C., Dina, R. C., et al. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.11.006 · Cited by 45
Treating hyperglycemia in early pregnancy: a randomized controlled trial
Roeder, H. A., Moore, T. R., Wolfson, M. T., Gamst, A. C., & Ramos, G. A. (2019) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2019.03.003 · Cited by 39
Monteiro, L. J., Varas‐Godoy, M., Mönckeberg, M., Realini, O., Hernández, M., Rice, G. E., Romero, R. J., Saavedra, J. F., Illanes, S. E., & Chaparro, A. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218616 · Cited by 44
Cheng, Y., Li, T., He, M., Liu, J., Wu, K., Liu, S., Ma, Z., Lu, J., Zhang, Q., & Cheng, H. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0542-6 · Cited by 45
Dysglycemia in Pregnancy and Maternal/Fetal Outcomes
Silva, C. M., Arnegard, M. E., & Maric‐Bilkan, C. (2021) · Journal of Women s Health · doi:10.1089/jwh.2020.8853 · Cited by 50
Placental secretome characterization identifies candidates for pregnancy complications
Napso, T., Zhao, X., Ibañez‐Lligoña, M., Sandovici, I., Kay, R. G., George, A. L., Gribble, F. M., Reimann, F., Meek, C. L., Hamilton, R. S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02214-x · Cited by 47
An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review
Minschart, C., Beunen, K., & Benhalima, K. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s287121 · Cited by 48
Wang, J., Lv, B., Chen, X., Pan, Y., Chen, K., Zhang, Y., Li, Q., Wei, L. S., & Liu, Y. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04295-2 · Cited by 46
Gestational Glucose Intolerance and Risk of Future Diabetes
Selen, D. J., Thaweethai, T., Schulte, C. C. M., Hsu, S. C., He, W. W., James, K. E., Kaimal, A. J., Meigs, J. B., & Powe, C. E. (2022) · Diabetes Care · doi:10.2337/dc22-1390 · Cited by 41
Xie, X., Gao, H., Zeng, W., Chen, S., Feng, L., Deng, D., Qiao, F., Liao, L., McCormick, K. L., Ning, Q., et al. (2015) · Clinical Science · doi:10.1042/cs20140688 · Cited by 46
Maleki, N., & Tavosi, Z. (2014) · Diabetic Medicine · doi:10.1111/dme.12580 · Cited by 47
Donovan, L. E., Savu, A., Edwards, A. L., Johnson, J. A., & Kaul, P. (2016) · Diabetes Care · doi:10.2337/dc15-1421 · Cited by 37
“The International Association of the Diabetes and Pregnancy Study Groups (18) has recommended that the GDS be abandoned in favor of a one-step diagnostic 75-g OGTT.”
BackgroundLeng, J., Zhang, C., Wang, P., Li, N., Li, W., Liu, H., Zhang, S., Hu, G., Yu, Z., Ronald, C. W., et al. (2016) · Scientific Reports · doi:10.1038/srep27291 · Cited by 44
Ekinci, E. I., Torkamani, N., Ramchand, S. K., Churilov, L. P., Sikaris, K. A., Lu, Z. X., & Houlihan, C. A. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12634 · Cited by 42
GCK, GCKR, FADS1, DGKB/TMEM195 and CDKAL1 Gene Polymorphisms in Women with Gestational Diabetes
Tarnowski, M., Malinowski, D., Pawlak, K. M., Dziedziejko, V., Safranow, K., & Pawlik, A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.11.009 · Cited by 44
Palm, C. V. B., Glintborg, D., Kyhl, H. B., McIntyre, H. D., Jensen, R. C., Jensen, T. K., Jensen, D. M., & Andersen, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.030 · Cited by 41
Kim, K.-S., Hong, S., Han, K., & Park, C.-Y. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2020.948 · Cited by 40
One-step or 2-step testing for gestational diabetes: which is better?
Coustan, D. R., Dyer, A. R., & Metzger, B. E. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.05.009 · Cited by 40
The emerging role of metformin in gestational diabetes mellitus
Gray, S. G., McGuire, T. M., Cohen, N., & Little, P. J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12893 · Cited by 40
Papachatzopoulou, E., Chatzakis, C., Lambrinoudaki, I., Panoulis, K., Dinas, K., Vlahos, N., Sotiriadis, A., & Eleftheriades, M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108048 · Cited by 40
Mahai, G., Wan, Y., Wang, A., Qian, X., Li, J., Li, Y., Zhang, W., He, Z., Li, Y., Xia, W., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108173 · Cited by 44
Zhen, J., Gu, Y., Wang, P., Wang, W., Bian, S., Huang, S., Liang, H., Huang, M., Yu, Y., Chen, Q., et al. (2024) · Diabetologia · doi:10.1007/s00125-023-06065-5 · Cited by 39
“The global prevalence of GDM has significantly increased over the past few decades, affecting 16.7% of pregnant women worldwide, with an estimated 21 million livebirths affected in 2021 [2].”
InfluentialEmergency Room Utilization After Medically Complicated Pregnancies: A Medicaid Claims Analysis
Harris, A., Chang, H., Wang, L., Sylvia, M. L., Neale, D. M., Levine, D. M., & Bennett, W. L. (2015) · Journal of Women s Health · doi:10.1089/jwh.2014.5125 · Cited by 42
Evaluation of circulating betatrophin levels in gestational diabetes mellitus
Erol, O. Ö., Ellidağ, H. Y., Ayık, H., Özel, M. K., Derbent, A. U., & Yılmaz, N. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1056142 · Cited by 43
Probiotics: a potential role in the prevention of gestational diabetes?
Barrett, H. L., Callaway, L. K., & Nitert, M. D. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0444-8 · Cited by 46
Hayes, L., Bell, R., Robson, S., Poston, L., & on behalf of the UPBEAT Consortium (2014) · Annals of Nutrition and Metabolism · doi:10.1159/000365027 · Cited by 39
Prediction of Gestational Diabetes Early in Pregnancy: Targeting the Long-Term Complications
Correa, P. J., Vargas, F., Sen, S., & Illanes, S. E. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000357616 · Cited by 46
Inadequacy of the risk factor based approach to detect gestational diabetes mellitus
Dahanayaka, N., Agampodi, S., Ranasinghe, O., Jayaweera, P., Wickramasinghe, W., Adhikari, A., Chathurani, H., & Dissanayaka, U. (2012) · Ceylon Medical Journal · doi:10.4038/cmj.v57i1.4193 · Cited by 38
BMI-Independent Effects of Gestational Diabetes on Human Placenta
Stirm, L., Kovářová, M., Perschbacher, S., Michlmaier, R., Fritsche, L., Siegel-Axel, D. I., Schleicher, E. D., Peter, A., Pauluschke‐Fröhlich, J., Brucker, S. Y., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00397 · Cited by 45
Gestational diabetes and postnatal depressive symptoms: A prospective cohort study in Western China
Mak, J. K. L., Lee, A. H., Pham, N. M., Tang, L., Pan, X., Binns, C. W., & Sun, X. (2018) · Women and Birth · doi:10.1016/j.wombi.2018.08.171 · Cited by 46
Sampaio, A. F. S., da Rocha, M. J. F., & Leal, E. A. S. (2018) · Revista Brasileira de Saúde Materno Infantil · doi:10.1590/1806-93042018000300007 · Cited by 105
Wang, X., Zhang, X., Zhou, M., Juan, J., & Wang, X. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5516937 · Cited by 44
Shahriari, A., Karimi, E., Shahriari, M., Aslani, N., Khooshideh, M., & Arab, A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111915 · Cited by 46
Continuous Glucose Monitoring in Women with Normal OGTT in Pregnancy
Tartaglione, L., Stasio, E. D., Sirico, A., Leo, M. A. S. D., Caputo, S., Rizzi, A., Caneschi, A., Carolis, S. D., Pitocco, D., & Lanzone, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9987646 · Cited by 43
Zhu, Q., Xu, Y., Zhang, Y., Shan, C., & Shi, Z. (2022) · mSystems · doi:10.1128/msystems.00465-22 · Cited by 41
“The criteria of the International Association of the Diabetes and Pregnancy Study Group (IADPSG) were used to diagnose GDM (38).”
MethodDoi, S. A. R., Furuya‐Kanamori, L., Toft, E., Musa, O. A. H., Islam, N., Clark, J., & Thalib, L. (2020) · Obesity Reviews · doi:10.1111/obr.12964 · Cited by 39
Socio‐economic status and risk of gestational diabetes mellitus among Chinese women
Song, L., Shen, L., Li, H., Liu, B., Zheng, X., Zhang, L., Xu, S., & Wang, Y. (2017) · Diabetic Medicine · doi:10.1111/dme.13415 · Cited by 39
Time in range in pregnancy: is there a role?
Wyckoff, J. A., & Brown, F. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0103 · Cited by 39
Fraticelli, F., Celentano, C., Zecca, I. A., Di Vieste, G., Pintaudi, B., Liberati, M., Franzago, M., Di Nicola, M., & Vitacolonna, E. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1157-4 · Cited by 39
Kirke, A. B., Atkinson, D., Moore, S., Sterry, K., Singleton, S., Roxburgh, C., Parrish, K., Porter, C., & Marley, J. V. (2019) · Australian Journal of Rural Health · doi:10.1111/ajr.12465 · Cited by 38
Roverso, M., Brioschi, M., Banfi, C., Visentin, S., Burlina, S., Seraglia, R., Traldi, P., & Lapolla, A. (2016) · European Journal of Mass Spectrometry · doi:10.1255/ejms.1412 · Cited by 37
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.